SIZE: | 40 capsules |
---|---|
COMPOSITION | Molnupiravir |
Strength | 200mg |
Molnupiravir 200mg Capsule
Molnucap (Molnupiravir) belongs to the class of antivirals termed as Mutagenic Ribonucleosides. It prevents the replication and transcription of the viral genomes by introducing errors and changes in viral genetic material.
Molnucap (Molnupiravir) can be taken with or without food.
The recommended dosage of Molnucap (Molnupiravir) is 800mg, (four 200mg capsules) every 8 hours for 5 days.
The safety and efficacy of Molnucap (Molnupiravir), if taken more than 5 days, have not been established.
Elderly: No dose adjustment is required.
Renal Impairment: No dose adjustment is required.
Hepatic Impairment: No dose adjustment is required.
Pediatric Population: No data is available for the administration of Molnupiravir in patients below 18 years of age.
Pregnancy: Molnupiravir is not recommended during pregnancy. The women of childbearing potential should use effective contraception during the treatment and for 4 days after the last dose of Molnupiravir.
Hypersensitivity to the active substance
Store at room temperature (up to 30°C)
It is an Anti-Bacterial product, used for bacterial infection in the vagina like Bacterial vaginosis. this cream is directly applied in the vagina with the help of applicator that is present inbox.
It’s a topical treatment of psoriasis and its types.